Changes in the immune and endocrine responses of patients with pulmonary tuberculosis undergoing specific treatment

Annals of the New York Academy of Sciences

Volumn 1262, Issue 1, 2012, Pages 10-15

  Bongiovanni, Bettina ^a   Díaz, Ariana ^a   D'Attilio, Luciano ^a   Santucci, Natalia ^a   Dídoli, Griselda ^a   Lioi, Susana ^b   Nannini, Luis J ^c   Gardeñez, Walter ^b   Bogue, Cristina ^d   Besedovsky, Hugo ^e   del Rey, Adriana ^e   Bottasso, Oscar ^a   Bay, María Luisa ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Hospital Centenario de Rosario   (Argentina)

^c Pulmonary Section   (Argentina)

^d Hospital I Carrasco   (Argentina)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Adrenal steroids; Cytokines; Etiological treatment; Immune endocrine changes; Tuberculosis

Indexed keywords

C REACTIVE PROTEIN; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PRASTERONE; PRASTERONE SULFATE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MALE; PROTEIN BLOOD LEVEL;

EID: 84864134020     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06643.x     Document Type: Article

References (21)

1. Comstock, G.W. 1982. Epidemiology of tuberculosis. Am. Rev. Respir. Dis. 125: 8-15.
2. Flynn, J.L. 2004. Immunology of tuberculosis and implications in vaccine development. Tuberculosis 84: 93-101.
3. del Rey, A., C.V. Mahuad, V.V. Bozza, et al. 2007. Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav. Immun. 21: 171-179.
4. Van den Berghe, G. 2003. Endocrine evaluation of patients with critical illness. Endocrinol. Metab. Clin. North Am. 32: 385-410.
5. Besedovsky, H.O. & A. del Rey. 1996. Immune-neuro-endocrine interactions: facts and hypothesis. Endocr. Rev. 17: 64-95.
6. Elenkov, I.J. & G.P. Chrousos. 1999. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol. Metab. 10: 359-368.
7. Dillon, J. 2005. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr. Drug Targets Inflamm. Allergy 4: 377-385.
8. Bozza, V.V., L. D'Attilio, C.V. Mahuad, et al. 2007. Altered Cortisol/DHEA ratio in tuberculosis patients and its relationship with abnormalities in the mycobacterial-driven cytokine production by peripheral blood mononuclear cells. Scand. J. Immunol. 66: 97-103.
9. Santucci, N., L. DAttilio, L. Kovalevski, et al. 2011. A multifaceted analysis of immune-endocrine-metabolic alterations in patients with pulmonary tuberculosis. PLoS One 6: e26363.
10. Mahuad, C., M.L. Bay, M.A. Farroni, et al. 2004. Cortisol and dehydroepiandrosterone affect the response of peripheral blood mononuclear cells to mycobacterial antigens during tuberculosis. Scand. J. Immunol. 60: 639-646.
11. Turnbull, A.V. & C. Rivier. 1995. Regulation of the HPA axis by cytokines. Brain Behav. Immun. 9: 253-275.
12. Mahuad, C., V. Bozza, S.M. Pezzotto, et al. 2007. Impaired immune responses in tuberculosis patients are related to weight loss that coexists with an immunoendocrine imbalance. Neuroimmunomodulation 14: 193-199.
13. van Lettow, M., J.W.M. van der Meer, C.E. West, et al. 2005. Interleukin-6 and human immunodeficiency virus load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi. J. Clin. Endocrinol. Metab. 90: 4771-4776.
14. Nagabhushanam, V., A. Solache, L.M. Ting, et al. 2003. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-γ. J. Immunol. 171: 4750-4757.
15. Choi, C.M., C.I. Kang, W.K. Jeung, et al. 2007. Role of the C-reactive protein for the diagnosis of TB among military personnel in South Korea. Int. J. Tuberc. Lung Dis. 11: 233-236.
16. Breen, R.A., O. Leonard, F.M Perrin, et al. 2008. How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis? Int. J. Tuberc. Lung Dis. 12: 44-49.
17. Straub, R.H. & H.O. Besedovsky. 2003. Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J. 17: 2176-2183.
18. Jäättelä, M., O. Carpen, U.H Stenman & E. Saksela. 1990. Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-alpha. Mol. Cell Endocrinol. 68: R31-R36.
19. Rosenfeld, R.S., L. Hellman & T.F. Gallagher. 1972. Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate. J. Clin. Endocrinol. Metab. 35: 87-193.
20. Katzung, B., S. Masters & A. Trevor. 2009. Basic and Clinical Pharmacology, 11th Ed. McGraw-Hill. New York.
21. Francois Venter, W.D., V.R. Panz, C. Feldman & B.I. Joffe. 2006. Adrenocortical function in hospitalised patients with active pulmonary tuberculosis receiving a rifampicin-based regimen-a pilot study. S. Afr. Med. J. 96: 62-66.